The upcoming changes to the preeminent US vancomycin dosing guidelines have been greatly anticipated by the pharmacy and infectious disease community for some time. The recent draft release of these guidelines has prompted significant discussion by the recommendation supporting a switch from traditional trough serum concentration measurement to...
Read more
MOORESTOWN, N.J., (June 13, 2019) - Tabula Rasa HealthCare, Inc.’s (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced a multi-year partnership agreement between its precision dosing software subsidiary DoseMe and Houston Methodist for the system-wide implementation of DoseMe’s proprietary dose optimization software,...
Read more
MOORESTOWN, N.J., (June 6, 2019) - Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), precision dosing software company DoseMe, today announced a three-year agreement with Portugal’s National Health Service, Centro Hospitalar Lisboa Ocidental (CHLO) for DoseMe’s proprietary dose optimization software - DoseMeRx. “Therapeutic drug monitoring of medications...
Read more
This June, DoseMe is exhibiting at the American Society of Health System Pharmacists (ASHP) Summer Meeting from June 8th - 12th in Boston. With the recent recommended changes to the vancomycin therapeutic guideline we will be demonstrating how DoesMeRx - DoseMe's proprietary precision dosing software - helps simplify AUC-based decision...
Read moreHIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2019 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.
